We recently spoke with Eric Le Royer, CEO of Geneva-based Endosense, about how his company applied MEMS technology to the development of a new catheter to improve the procedures for treating atrial fibrillation. According to Mr. Le Royer, atrial fibrillation is today’s most prevalent cardiac rhythm disorder and is estimated to affect more than 6 million people worldwide. Of these, approximately 2.6 million cases have been treated by three types of therapy – 2.5 million with drugs, 60,000 with surgery and 70,000 with conventional catheter ablation. The catheter market for treating atrial cardiac disorder is expected to grow from $500 million today at a rate of 20% per annum and reach $1.25 billion in 2015.
Continue reading "MEMS application for treating cardiac rhythm disorder" »
We recently spoke with Marco Boella, CEO and Dr. Nicolas Abelé, CTO of Lemoptix, based near Lausanne, Switzerland, about their work to integrate high-resolution MEMS-based micro projection technology into information display systems, mobile phones and other applications. According to Lemoptix, the largest market will be in embedded applications in mobile devices, such as mobile phones, laptops, digital still cameras and gaming. The micro projection market is estimated to be worth $2 billion by 2012.
Continue reading "MEMS technology for micro projection modules" »
We recently spoke with Marius Domokos, an IP attorney specializing in strategic counseling for technology companies, who also worked as an in-house IP attorney for KLA-Tencor and Intel. Here Marius shares some thoughts on how the MEMS industry should approach IP protection.
Continue reading "MEMS and semiconductors IP strategies " »
